RENOVORX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
RENOVORX, INC. (RNXT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-13
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 0.00 shares.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 0.00 shares.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 30.88K shares, a 55.56% decline year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 5.00K shares.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 68.66K shares, a 61.16% decline from fiscal 2024.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 176.77K shares, a 4539.74% increase from fiscal 2023.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 3.81K shares.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2021 was 82.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 0.00 shares 10-Q · filed 2026-08-13 | 30.88K shares derived: sum of 3 quarters · filed 2026-08-13 | 35.88K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-14 | 30.88K shares derived: sum of 2 quarters · filed 2026-05-14 | 35.88K shares derived: sum of 3 quarters · filed 2026-05-14 | |
| 2025-12-31 | 30.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 35.88K shares derived: sum of 2 quarters · filed 2026-03-30 | 68.66K shares 10-K · filed 2026-03-30 | |
| 2025-09-30 | 5.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 37.78K shares 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | 32.78K shares 10-Q · filed 2025-08-14 | |||
| 2024-12-31 | 69.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | 69.50K shares derived: sum of 2 quarters · filed 2025-04-01 | 176.77K shares 10-K · filed 2025-04-01 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 107.28K shares 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | 107.28K shares 10-Q · filed 2024-08-13 | |||
| 2023-12-31 | 3.81K shares 10-K · filed 2024-04-01 | |||
| 2021-12-31 | -1.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 82.00 shares 10-K · filed 2022-03-30 | ||
| 2021-09-30 | 83.00 shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |